跳至主要内容
临床试验/NCT01933750
NCT01933750已完成不适用

A Prospective, Multicenter, Controlled Clinical Study of the PresVIEW Scleral Implant for the Improvement of Near Visual Acuity in Presbyopic Patients

Refocus Ocular Europe, B.V.1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2013年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
20
试验地点
1
主要终点
Near Visual Acuity

研究概览

简要总结

Study to determine the effectiveness of the PresVIEW Scleral Implant to improve near vision in patients who require reading glasses

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
45 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Age 45 or older at commencement of study
  • Best Corrected Distance Visual Acuity of .80 (20/25) or better
  • Patients must be alert, mentally competent, and able to comply with clinical study requirements

排除标准

  • Any previous eye surgeries including cataract, LASIK (laser in situ keratomileusis), or eye muscle surgery
  • Any chronic systemic diseases such as diabetes, heart disease, Lupus, etc.
  • Any eye diseases such as eye inflammation, infection, cataract, or retinal diseases

结局指标

主要结局

Near Visual Acuity

时间窗: 12 Months

Measurement of the distance Corrected Near Visual Acuity at 40 centimeters compared to baseline measurement. A minimum of 75% of patients with a bilateral post-operative Distance Corrected Near Visual Acuity of .5 (20/40) or better at 12 months

次要结局

  • Presence of Significant Safety Events(24 months)
  • Uncorrected Near Visual Acuity(12 Months)

研究者

发起方
Refocus Ocular Europe, B.V.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验